Skip to main content

Table 1 Baseline characteristics of enrolled patients

From: Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study

Table 1

CKD Stages I-V

Control group

p

N=80

N=24

Age

67.2 ± 11.7

61.2 ± 9.6

0.042

Gender (males %)

56.2%

29.2%

0.01

Diabetes mellitus

33.3%

0%

0.0022

Atrial fibrillation

20.83%

13.79%

NS

Hypertension

88.3%

37.5%

<0.0001

Lipid disorders

30.6%

41.4%

0.039

Heart failure

63.9%

0%

<0.0001

Hypertensive nephropathy

5.6%

0%

NS

Diabetic nephropathy

4.2%

0%

NS

Beta-blockers

61%

20,8%

<0.007

CA-blockers

40.5%

8.3%

0.004

ACE inhibitors

69.6%

41%

0.011

Diuretics

90.5%

16.7%

<0.0001

Statins

97.5%

43%

<0.0001

Erythropoietina

5.6%a

0%

<0.0001

Mean dialysis vintage [months]a

27±9a

0

<0.0001

  1. a applies only to CKD stage V patients